home / press / releases

Menu
  • Search all tables

releases: https://walorski.house.gov/covid-vaccine-eua/

One row per release. Full-text search runs over title + body text.

Data license: MIT · Data source: dwillis/congress-press

This data as json

url title date year month party chamber state member_name bioguide_id domain scraper source date_source text has_text collected_at updated_at
https://walorski.house.gov/covid-vaccine-eua/ Walorski Statement on FDA Approval of First COVID-19 Vaccine 2020-12-11 2020 2020-12 Republican House IN Jackie Walorski W000813 walorski.house.gov     legacy Friday, December 11, 2020 Walorski Statement on FDA Approval of First COVID-19 Vaccine Vaccine Found to Be Safe and More Than 90 Percent Effective After Extensive Clinical Trials, Comprehensive FDA Review WASHINGTON U.S. Rep. Jackie Walorski (R-Ind.) today released the following statement after the Food and Drug Administration (FDA) issued an emergency use authorization for the COVID-19 vaccine, developed by Pfizer and BioNTech: The approval of a safe and effective vaccine is a major step on the path to defeating coronavirus, restoring our way of life, and fully rebuilding our nation's economy. This historic breakthrough is a testament to America's innovative spirit and our determination to work together to find solutions when challenges confront us. I'm grateful to the scientists, health care workers, and trial volunteers who made this achievement possible, as well as to President Trump and his administration for their leadership to ensure vaccine doses will be distributed around the country without delay. The American people can be confident that this vaccine and any others approved by the FDA will be safe, effective, affordable, and widely available. I look forward to doing my part to end the pandemic by taking a vaccine once it is available to the public. Walorski represents the 2nd Congressional District of Indiana, serving as a member of the House Ways and Means Committee. ### 1 2026-03-30T12:14:52Z 2026-03-30T12:14:52Z
Powered by Datasette · Queries took 1.205ms · Data license: MIT · Data source: dwillis/congress-press